Mammary stem cell number as a determinate of breast cancer risk.
about
The Obesity-Breast Cancer Conundrum: An Analysis of the IssuesWound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancerExosomes-mediate microRNAs transfer in breast cancer chemoresistance regulationPygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylationGrowth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.Mammary development and breast cancer: the role of stem cellsThe number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia.Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments.Effect of preeclampsia on umbilical cord blood stem cells in relation to breast cancer susceptibility in the offspring.Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life.Prenatal Maternal Physical Activity and Stem Cells in Umbilical Cord Blood.Correlation of umbilical cord blood haematopoietic stem and progenitor cell levels with birth weight: implications for a prenatal influence on cancer risk.Prenatal modulation of breast density and breast stem cells by insulin-like growth factor-1.Cancer stem cells and the ontogeny of lung cancerThe contribution of growth hormone to mammary neoplasiaImplications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian womenNuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.The tissue-specific stem cell as a target for chemoprevention.The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells.Tissue-based associations of mammographic breast density with breast stem cell markers.Prognostic impact of CD133 expression in Endometrial Cancer Patients.Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.Role of the growth hormone–IGF-1 axis in cancer
P2860
Q26747486-893EE02C-22FC-4B11-B50C-647E7585402EQ27023599-F2138D4D-24D0-4620-ACCE-68A568B173F0Q28066991-CB7CCC5B-3576-4FEC-ACD4-B42E428DFF29Q28588630-67D6665A-16DB-4228-9143-8D72549D5D28Q33569159-14C0EEED-9A74-411E-8F15-02734AF2EBD0Q33627153-2D719333-9C4C-4EED-B2DE-92072E98E432Q33735595-9917F37F-F420-480A-A752-9B722C2D3BF3Q33874174-87ABB346-6054-4CB3-9D22-5EBD62992742Q34059673-E29EDAC9-0099-4281-AB3D-3F7AF7FCFF99Q34103289-C362C9F5-9058-4A3B-881E-CA12EFED6FC5Q34918027-D5D862CB-3AB3-41CA-AC49-E07F414C54ABQ35747294-8ABFFB7F-E53F-4C23-81A8-44694D4167FFQ36378007-55CD014A-06F2-476F-8A8B-78B3BD70CC47Q36459783-6A88E8C8-DF35-4ACC-A318-53733A458366Q36796406-7A328C1C-BCA4-4445-BE13-5D4E652A5409Q37000182-564ACF02-3E34-4354-B315-804F5CB0C395Q37078157-7F5F9C4A-9FB7-4049-9649-B47B07B7FF03Q37186412-E5629104-9E4C-4306-A130-8D2E5572CDDEQ37300959-D9930D8C-47E9-4089-BFCB-8FAE176B22D5Q37420064-A9857E85-6F62-4674-B1C2-5AD49F6183C0Q37810502-519C6477-4A5A-4E9D-A940-564B3BD69C9DQ38263985-FA3FDD87-FDE3-4957-BA2E-2E3202D2DB63Q40066307-7CE27937-A694-414D-88B6-D6C4EA3A99B0Q41332330-473C1A6F-26EB-41EE-9058-4700EB3C1D23Q47103096-BE7E961E-8FFA-4D1B-AB18-73BFCDAD1DB3Q57252658-0F493A86-9B11-49D2-A05F-36DED1E84101
P2860
Mammary stem cell number as a determinate of breast cancer risk.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mammary stem cell number as a determinate of breast cancer risk.
@en
Mammary stem cell number as a determinate of breast cancer risk.
@nl
type
label
Mammary stem cell number as a determinate of breast cancer risk.
@en
Mammary stem cell number as a determinate of breast cancer risk.
@nl
prefLabel
Mammary stem cell number as a determinate of breast cancer risk.
@en
Mammary stem cell number as a determinate of breast cancer risk.
@nl
P2860
P356
P1476
Mammary stem cell number as a determinate of breast cancer risk
@en
P2093
Max S Wicha
P2860
P2888
P356
10.1186/BCR1741
P577
2007-01-01T00:00:00Z
P5875
P6179
1042036207